Congress Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-5,395
Closed -$479K 391
2017
Q2
$479K Buy
5,395
+150
+3% +$12.6K 0.01% 228
2017
Q1
$423K Hold
5,245
0.01% 229
2016
Q4
$374K Buy
5,245
+655
+14% +$51.5K 0.01% 233
2016
Q3
$397K Buy
4,590
+115
+3% +$10K 0.01% 200
2016
Q2
$388K Sell
4,475
-2,440
-35% -$197K 0.01% 205
2016
Q1
$519K Buy
6,915
+1,440
+26% +$108K 0.01% 192
2015
Q4
$421K Hold
5,475
0.01% 205
2015
Q3
$366K Sell
5,475
-9
-0.2% -$663 0.01% 193
2015
Q2
$406K Buy
5,484
+5
+0.1% +$382 0.01% 203
2015
Q1
$427K Sell
5,479
-405
-7% -$30.7K 0.01% 197
2014
Q4
$425K Sell
5,884
-900
-13% -$62.5K 0.01% 205
2014
Q3
$420K Buy
6,784
+1,309
+24% +$83.2K 0.01% 206
2014
Q2
$349K Buy
5,475
+500
+10% +$30.4K 0.01% 213
2014
Q1
$306K Buy
4,975
+460
+10% +$26.8K 0.01% 217
2013
Q4
$259K Sell
4,515
-20,655
-82% -$1.17M 0.01% 214
2013
Q3
$1.34M Buy
25,170
+6,790
+37% +$365K 0.04% 175
2013
Q2
$946K Buy
+18,380
New +$909K 0.03% 175

Other funds holding MDT

Congress Asset Management's MDT Position: Q3 2017 in Review

Congress Asset Management sold out of Medtronic (MDT) in Q3 2017, closing a stake of 5,395 shares — an estimated $479K sold.

Congress Asset Management first reported a position in MDT in Q2 2013 and held it in 17 quarters. The position peaked at $1.34M in Q3 2013. 1,290 funds tracked by Wall St. Rank hold MDT as of Q3 2017.

  • Congress Asset Management reported no remaining Medtronic position as of Q3 2017 after selling out during the quarter.
  • Congress Asset Management sold 5,395 Medtronic shares in Q3 2017, an estimated $479K.
  • Congress Asset Management first reported a position in Medtronic in Q2 2013 and held it in 17 quarters.
  • Congress Asset Management's Medtronic position peaked at $1.34M in Q3 2013.
  • 1,290 funds tracked by Wall St. Rank held Medtronic as of Q3 2017.

Based on Congress Asset Management's 13F filing for Q3 2017, filed 17 Oct 2017.